It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The mammalian spermatozoa produced in the testis require functional maturation in the epididymis for their full competence. Epididymal sperm maturation is regulated by lumicrine signalling pathways in which testis-derived secreted signals relocate to the epididymis lumen and promote functional differentiation. However, the detailed mechanisms of lumicrine regulation are unclear. Herein, we demonstrate that a small secreted protein, NELL2-interacting cofactor for lumicrine signalling (NICOL), plays a crucial role in lumicrine signalling in mice. NICOL is expressed in male reproductive organs, including the testis, and forms a complex with the testis-secreted protein NELL2, which is transported transluminally from the testis to the epididymis. Males lacking Nicol are sterile due to impaired NELL2-mediated lumicrine signalling, leading to defective epididymal differentiation and deficient sperm maturation but can be restored by NICOL expression in testicular germ cells. Our results demonstrate how lumicrine signalling regulates epididymal function for successful sperm maturation and male fertility.
Mammalian sperm need to be matured in the epididymis to achieve potential for fertility. Here the authors identify NICOL as a secreted protein that acts on the epididymis to trigger its functional differentiation and induce sperm maturation.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details







1 Osaka University, Suita, Research Institute for Microbial Diseases, Osaka, Japan (GRID:grid.136593.b) (ISNI:0000 0004 0373 3971); PRESTO, Japan Science and Technology Agency, Kawaguchi, Saitama, Japan (GRID:grid.419082.6) (ISNI:0000 0004 1754 9200)
2 Osaka University, Suita, Research Institute for Microbial Diseases, Osaka, Japan (GRID:grid.136593.b) (ISNI:0000 0004 0373 3971); Osaka University, Suita, Graduate School of Pharmaceutical Sciences, Osaka, Japan (GRID:grid.136593.b) (ISNI:0000 0004 0373 3971)
3 Tel Aviv University, Shmunis School for Biomedicine and Cancer Research, Ramat Aviv, Israel (GRID:grid.12136.37) (ISNI:0000 0004 1937 0546)
4 Osaka University, Suita, Research Institute for Microbial Diseases, Osaka, Japan (GRID:grid.136593.b) (ISNI:0000 0004 0373 3971)
5 Baylor College of Medicine, Center for Drug Discovery and Department of Pathology & Immunology, Houston, USA (GRID:grid.39382.33) (ISNI:0000 0001 2160 926X)
6 Osaka University, Suita, Research Institute for Microbial Diseases, Osaka, Japan (GRID:grid.136593.b) (ISNI:0000 0004 0373 3971); Osaka University, Suita, Graduate School of Pharmaceutical Sciences, Osaka, Japan (GRID:grid.136593.b) (ISNI:0000 0004 0373 3971); Osaka University, Suita, Graduate School of Medicine, Osaka, Japan (GRID:grid.136593.b) (ISNI:0000 0004 0373 3971); The University of Tokyo, Minato-ku, The Institute of Medical Science, Tokyo, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X); CREST, Japan Science and Technology Agency, Kawaguchi, Saitama, Japan (GRID:grid.419082.6) (ISNI:0000 0004 1754 9200)